Taxonomy development for term standardization in activity resulting from medication review processes: a Delphi study
Abstract Background Medication review (MR) is the systematic assessment of a patient’s medications for safety and effectiveness by a healthcare professional. The language used to describe MR activity, such as stopped medicine and increased dose, should be consistent across studies to assist research...
Gespeichert in:
| Veröffentlicht in: | The International journal of pharmacy practice 2024-03, Vol.32 (2), p.180-185 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 185 |
|---|---|
| container_issue | 2 |
| container_start_page | 180 |
| container_title | The International journal of pharmacy practice |
| container_volume | 32 |
| creator | Alharthi, Mohammed S Scott, Sion Hughes, Carmel Bond, Christine Hatah, Ernieda Bryant, Linda Holland, Richard Kosari, Sam Baqir, Wasim Loke, Yoon Wright, David |
| description | Abstract
Background
Medication review (MR) is the systematic assessment of a patient’s medications for safety and effectiveness by a healthcare professional. The language used to describe MR activity, such as stopped medicine and increased dose, should be consistent across studies to assist researchers compare how different services operate and identify their mechanism of impact.
Aim
To develop an international taxonomy of standardized terms and activity definitions related to medication reviews.
Method
This was a three-stage Delphi-based consensus study with international medication review experts. A systematic review provided MR activity terms for the survey. Experts rated their consensus on each activity term and its definition on a Likert scale and provided written feedback. The consensus was 75% panel agreement. At each stage, consensus elements were retained, and feedback was used to revise definitions.
Results
Seven experts were recruited for the study (response rate 15.2%) from four countries: the United Kingdom (n = 4), New Zealand (n = 1), Australia (n = 1), and Malaysia (n = 1). The following terms achieved consensus: the term Medication as a descriptor for MR terms; discontinue medication, start medication, dose increase, dose decrease, dosage form change, and medication safety and efficacy monitor to describe MR activity; Educate to describe the delivery of healthcare professionals and patients/carers education.
Conclusion
Standardized medication review activity terms and definitions have been selected for universal adoption in all future MR research to facilitate a meaningful comparison of process evaluations within different settings. |
| doi_str_mv | 10.1093/ijpp/riae002 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2938285973</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/ijpp/riae002</oup_id><sourcerecordid>2938285973</sourcerecordid><originalsourceid>FETCH-LOGICAL-c318t-e4979f19bd0fbe4f6878d94e6623e153ed423abf7786016b7cf3d94617f30d2f3</originalsourceid><addsrcrecordid>eNp9kD1PwzAQQC0EoqWwMSNvMBBqx6ntsKHyKVViKXPkxGcwSuJgO4Xy60nVwsh0wz093T2ETim5oiRnU_vedVNvFRCS7qFxSrI0EVRk-2hMck4TwQUdoaMQ3geAz6Q4RCMmmRScyDGKS_XlWtessYYV1K5roI3YOI8j-AaHqFqtvLbfKlrXYttiVUW7snGNPYS-jrZ9xca7BjegbbWlPKwsfOLOuwpCgHCNFb6Funuzg7DX62N0YFQd4GQ3J-jl_m45f0wWzw9P85tFUjEqYwJZLnJD81ITU0JmuBRS5xlwnjKgMwY6S5kqjRCSE8pLURk27DkVhhGdGjZBF1vvcMlHDyEWjQ0V1LVqwfWhSHMmUznLBRvQyy1aeReCB1N03jbKrwtKik3nYtO52HUe8LOduS-Hx__g37ADcL4FXN_9r_oBc6qK6Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2938285973</pqid></control><display><type>article</type><title>Taxonomy development for term standardization in activity resulting from medication review processes: a Delphi study</title><source>MEDLINE</source><source>Oxford University Press Journals All Titles (1996-Current)</source><creator>Alharthi, Mohammed S ; Scott, Sion ; Hughes, Carmel ; Bond, Christine ; Hatah, Ernieda ; Bryant, Linda ; Holland, Richard ; Kosari, Sam ; Baqir, Wasim ; Loke, Yoon ; Wright, David</creator><creatorcontrib>Alharthi, Mohammed S ; Scott, Sion ; Hughes, Carmel ; Bond, Christine ; Hatah, Ernieda ; Bryant, Linda ; Holland, Richard ; Kosari, Sam ; Baqir, Wasim ; Loke, Yoon ; Wright, David</creatorcontrib><description>Abstract
Background
Medication review (MR) is the systematic assessment of a patient’s medications for safety and effectiveness by a healthcare professional. The language used to describe MR activity, such as stopped medicine and increased dose, should be consistent across studies to assist researchers compare how different services operate and identify their mechanism of impact.
Aim
To develop an international taxonomy of standardized terms and activity definitions related to medication reviews.
Method
This was a three-stage Delphi-based consensus study with international medication review experts. A systematic review provided MR activity terms for the survey. Experts rated their consensus on each activity term and its definition on a Likert scale and provided written feedback. The consensus was 75% panel agreement. At each stage, consensus elements were retained, and feedback was used to revise definitions.
Results
Seven experts were recruited for the study (response rate 15.2%) from four countries: the United Kingdom (n = 4), New Zealand (n = 1), Australia (n = 1), and Malaysia (n = 1). The following terms achieved consensus: the term Medication as a descriptor for MR terms; discontinue medication, start medication, dose increase, dose decrease, dosage form change, and medication safety and efficacy monitor to describe MR activity; Educate to describe the delivery of healthcare professionals and patients/carers education.
Conclusion
Standardized medication review activity terms and definitions have been selected for universal adoption in all future MR research to facilitate a meaningful comparison of process evaluations within different settings.</description><identifier>ISSN: 0961-7671</identifier><identifier>EISSN: 2042-7174</identifier><identifier>DOI: 10.1093/ijpp/riae002</identifier><identifier>PMID: 38387608</identifier><language>eng</language><publisher>UK: Oxford University Press</publisher><subject>Consensus ; Delphi Technique ; Health Personnel ; Humans ; Medication Review ; Reference Standards</subject><ispartof>The International journal of pharmacy practice, 2024-03, Vol.32 (2), p.180-185</ispartof><rights>The Author(s) 2024. Published by Oxford University Press on behalf of the Royal Pharmaceutical Society. 2024</rights><rights>The Author(s) 2024. Published by Oxford University Press on behalf of the Royal Pharmaceutical Society.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c318t-e4979f19bd0fbe4f6878d94e6623e153ed423abf7786016b7cf3d94617f30d2f3</cites><orcidid>0000-0001-9109-2307 ; 0000-0002-8628-2832 ; 0000-0002-4656-6021 ; 0000-0003-0429-5208 ; 0000-0002-6737-1442</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,782,786,1586,27933,27934</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38387608$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Alharthi, Mohammed S</creatorcontrib><creatorcontrib>Scott, Sion</creatorcontrib><creatorcontrib>Hughes, Carmel</creatorcontrib><creatorcontrib>Bond, Christine</creatorcontrib><creatorcontrib>Hatah, Ernieda</creatorcontrib><creatorcontrib>Bryant, Linda</creatorcontrib><creatorcontrib>Holland, Richard</creatorcontrib><creatorcontrib>Kosari, Sam</creatorcontrib><creatorcontrib>Baqir, Wasim</creatorcontrib><creatorcontrib>Loke, Yoon</creatorcontrib><creatorcontrib>Wright, David</creatorcontrib><title>Taxonomy development for term standardization in activity resulting from medication review processes: a Delphi study</title><title>The International journal of pharmacy practice</title><addtitle>Int J Pharm Pract</addtitle><description>Abstract
Background
Medication review (MR) is the systematic assessment of a patient’s medications for safety and effectiveness by a healthcare professional. The language used to describe MR activity, such as stopped medicine and increased dose, should be consistent across studies to assist researchers compare how different services operate and identify their mechanism of impact.
Aim
To develop an international taxonomy of standardized terms and activity definitions related to medication reviews.
Method
This was a three-stage Delphi-based consensus study with international medication review experts. A systematic review provided MR activity terms for the survey. Experts rated their consensus on each activity term and its definition on a Likert scale and provided written feedback. The consensus was 75% panel agreement. At each stage, consensus elements were retained, and feedback was used to revise definitions.
Results
Seven experts were recruited for the study (response rate 15.2%) from four countries: the United Kingdom (n = 4), New Zealand (n = 1), Australia (n = 1), and Malaysia (n = 1). The following terms achieved consensus: the term Medication as a descriptor for MR terms; discontinue medication, start medication, dose increase, dose decrease, dosage form change, and medication safety and efficacy monitor to describe MR activity; Educate to describe the delivery of healthcare professionals and patients/carers education.
Conclusion
Standardized medication review activity terms and definitions have been selected for universal adoption in all future MR research to facilitate a meaningful comparison of process evaluations within different settings.</description><subject>Consensus</subject><subject>Delphi Technique</subject><subject>Health Personnel</subject><subject>Humans</subject><subject>Medication Review</subject><subject>Reference Standards</subject><issn>0961-7671</issn><issn>2042-7174</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>TOX</sourceid><sourceid>EIF</sourceid><recordid>eNp9kD1PwzAQQC0EoqWwMSNvMBBqx6ntsKHyKVViKXPkxGcwSuJgO4Xy60nVwsh0wz093T2ETim5oiRnU_vedVNvFRCS7qFxSrI0EVRk-2hMck4TwQUdoaMQ3geAz6Q4RCMmmRScyDGKS_XlWtessYYV1K5roI3YOI8j-AaHqFqtvLbfKlrXYttiVUW7snGNPYS-jrZ9xca7BjegbbWlPKwsfOLOuwpCgHCNFb6Funuzg7DX62N0YFQd4GQ3J-jl_m45f0wWzw9P85tFUjEqYwJZLnJD81ITU0JmuBRS5xlwnjKgMwY6S5kqjRCSE8pLURk27DkVhhGdGjZBF1vvcMlHDyEWjQ0V1LVqwfWhSHMmUznLBRvQyy1aeReCB1N03jbKrwtKik3nYtO52HUe8LOduS-Hx__g37ADcL4FXN_9r_oBc6qK6Q</recordid><startdate>20240306</startdate><enddate>20240306</enddate><creator>Alharthi, Mohammed S</creator><creator>Scott, Sion</creator><creator>Hughes, Carmel</creator><creator>Bond, Christine</creator><creator>Hatah, Ernieda</creator><creator>Bryant, Linda</creator><creator>Holland, Richard</creator><creator>Kosari, Sam</creator><creator>Baqir, Wasim</creator><creator>Loke, Yoon</creator><creator>Wright, David</creator><general>Oxford University Press</general><scope>TOX</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-9109-2307</orcidid><orcidid>https://orcid.org/0000-0002-8628-2832</orcidid><orcidid>https://orcid.org/0000-0002-4656-6021</orcidid><orcidid>https://orcid.org/0000-0003-0429-5208</orcidid><orcidid>https://orcid.org/0000-0002-6737-1442</orcidid></search><sort><creationdate>20240306</creationdate><title>Taxonomy development for term standardization in activity resulting from medication review processes: a Delphi study</title><author>Alharthi, Mohammed S ; Scott, Sion ; Hughes, Carmel ; Bond, Christine ; Hatah, Ernieda ; Bryant, Linda ; Holland, Richard ; Kosari, Sam ; Baqir, Wasim ; Loke, Yoon ; Wright, David</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c318t-e4979f19bd0fbe4f6878d94e6623e153ed423abf7786016b7cf3d94617f30d2f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Consensus</topic><topic>Delphi Technique</topic><topic>Health Personnel</topic><topic>Humans</topic><topic>Medication Review</topic><topic>Reference Standards</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Alharthi, Mohammed S</creatorcontrib><creatorcontrib>Scott, Sion</creatorcontrib><creatorcontrib>Hughes, Carmel</creatorcontrib><creatorcontrib>Bond, Christine</creatorcontrib><creatorcontrib>Hatah, Ernieda</creatorcontrib><creatorcontrib>Bryant, Linda</creatorcontrib><creatorcontrib>Holland, Richard</creatorcontrib><creatorcontrib>Kosari, Sam</creatorcontrib><creatorcontrib>Baqir, Wasim</creatorcontrib><creatorcontrib>Loke, Yoon</creatorcontrib><creatorcontrib>Wright, David</creatorcontrib><collection>Access via Oxford University Press (Open Access Collection)</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The International journal of pharmacy practice</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Alharthi, Mohammed S</au><au>Scott, Sion</au><au>Hughes, Carmel</au><au>Bond, Christine</au><au>Hatah, Ernieda</au><au>Bryant, Linda</au><au>Holland, Richard</au><au>Kosari, Sam</au><au>Baqir, Wasim</au><au>Loke, Yoon</au><au>Wright, David</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Taxonomy development for term standardization in activity resulting from medication review processes: a Delphi study</atitle><jtitle>The International journal of pharmacy practice</jtitle><addtitle>Int J Pharm Pract</addtitle><date>2024-03-06</date><risdate>2024</risdate><volume>32</volume><issue>2</issue><spage>180</spage><epage>185</epage><pages>180-185</pages><issn>0961-7671</issn><eissn>2042-7174</eissn><abstract>Abstract
Background
Medication review (MR) is the systematic assessment of a patient’s medications for safety and effectiveness by a healthcare professional. The language used to describe MR activity, such as stopped medicine and increased dose, should be consistent across studies to assist researchers compare how different services operate and identify their mechanism of impact.
Aim
To develop an international taxonomy of standardized terms and activity definitions related to medication reviews.
Method
This was a three-stage Delphi-based consensus study with international medication review experts. A systematic review provided MR activity terms for the survey. Experts rated their consensus on each activity term and its definition on a Likert scale and provided written feedback. The consensus was 75% panel agreement. At each stage, consensus elements were retained, and feedback was used to revise definitions.
Results
Seven experts were recruited for the study (response rate 15.2%) from four countries: the United Kingdom (n = 4), New Zealand (n = 1), Australia (n = 1), and Malaysia (n = 1). The following terms achieved consensus: the term Medication as a descriptor for MR terms; discontinue medication, start medication, dose increase, dose decrease, dosage form change, and medication safety and efficacy monitor to describe MR activity; Educate to describe the delivery of healthcare professionals and patients/carers education.
Conclusion
Standardized medication review activity terms and definitions have been selected for universal adoption in all future MR research to facilitate a meaningful comparison of process evaluations within different settings.</abstract><cop>UK</cop><pub>Oxford University Press</pub><pmid>38387608</pmid><doi>10.1093/ijpp/riae002</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0001-9109-2307</orcidid><orcidid>https://orcid.org/0000-0002-8628-2832</orcidid><orcidid>https://orcid.org/0000-0002-4656-6021</orcidid><orcidid>https://orcid.org/0000-0003-0429-5208</orcidid><orcidid>https://orcid.org/0000-0002-6737-1442</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0961-7671 |
| ispartof | The International journal of pharmacy practice, 2024-03, Vol.32 (2), p.180-185 |
| issn | 0961-7671 2042-7174 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2938285973 |
| source | MEDLINE; Oxford University Press Journals All Titles (1996-Current) |
| subjects | Consensus Delphi Technique Health Personnel Humans Medication Review Reference Standards |
| title | Taxonomy development for term standardization in activity resulting from medication review processes: a Delphi study |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-03T00%3A42%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Taxonomy%20development%20for%20term%20standardization%20in%20activity%20resulting%20from%20medication%20review%20processes:%20a%20Delphi%20study&rft.jtitle=The%20International%20journal%20of%20pharmacy%20practice&rft.au=Alharthi,%20Mohammed%20S&rft.date=2024-03-06&rft.volume=32&rft.issue=2&rft.spage=180&rft.epage=185&rft.pages=180-185&rft.issn=0961-7671&rft.eissn=2042-7174&rft_id=info:doi/10.1093/ijpp/riae002&rft_dat=%3Cproquest_cross%3E2938285973%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2938285973&rft_id=info:pmid/38387608&rft_oup_id=10.1093/ijpp/riae002&rfr_iscdi=true |